GBS/CIDP Foundation of Canada

GBS/CIDP Foundation of Canada serves patients afflicted with Guillain-Barre Syndrome (GBS), Chronic Inflammatory Demyelination Polyneuropathy (CIDP), and variants, such as Multifocal Motor Neuropathy (MMN), with support, education, research, and advocacy.

We are a registered Canadian charity with a national Medical Advisory Board and a network of trained caring volunteers that support our patients and families so that no patient goes through these disorders alone. Our volunteers are giving back to the GBS, CIDP, and MMN community and will give hope to newly diagnosed patients and their families through their own experiences and recoveries.

Medical professionals are welcome to connect with the foundation for more information.

Brochures & Educational Resources:

Browse our educational content below including brochures about the foundation, side effects of IVIG treatments, Immunoglobulin and more.

download-GBS-brochure
immunoglobulin-brochure

Symptoms, Diagnostics and Treatments:

Guillain-Barré Syndrome is an inflammatory disorder of the peripheral nerves. Hover over the interactive boxes below to see signs of onset, diagnostic processes and treatments.

Validated by Dr. Vera Bril UHN, TGH and Dr. Hans Katzberg, UHN, TWH

Symptoms

  • Progressive weakness, often starting 1-2 weeks after viral infection, and spreading to all extremities
  • May be associated with bulbar weakness and impaired respiration leading to need for intensive care
  • Associated with loss of reflexes
  • May be painful; usually minimal sensory findings

Diagnostics

These practices assess GBS, aiding medical professionals to come to a diagnosis:

  • Nerve conduction studies show demyelination but can be normal in the first week
  • CSF shows elevated protein and normal cell count, but can be normal in first week

Treatment

  • High dose intravenous immunoglobulin (IVIG)
  • Plasma exchange
  • Once IVIG has been administered, a patient should be observed for 2-weeks prior to an alternate treatment being prescribed
  • Treatment within two weeks of onset provides maximal benefit

Video Content:

Watch below as we celebrate the triumph of and stories of the brave GBS, CIDP and MMN warriors.

Contact GBS/CIDP Foundation of Canada:

Online:

www.gbscidp.ca

Phone:

(647) 560-6842

Browse Additional Categories:

Go Back to EM Marketplace

OR

Go Back to Patient Care

RoyalCBD.com Royal CBD Royal CBD Creams